Pending EC decision: Ryzodeg, insulin degludec / insulin aspart, Opinion date: 18-Oct-2012
Go to Source
This entry was posted on Saturday, October 27th, 2012 at 11:30 pm and is filed under European Medicines Agency. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.